Published in S Afr Med J on May 11, 1968
'Green revolution' genes encode mutant gibberellin response modulators. Nature (1999) 8.87
The Arabidopsis GAI gene defines a signaling pathway that negatively regulates gibberellin responses. Genes Dev (1997) 7.30
LNCaP model of human prostatic carcinoma. Cancer Res (1983) 7.23
Is the new veterinary college a good model? J Am Vet Med Assoc (1998) 5.86
Interpretation of Emergency Department radiographs: a comparison of emergency medicine physicians with radiologists, residents with faculty, and film with digital display. AJR Am J Roentgenol (2000) 4.13
Bilateral Adrenalectomy in Prostatic Cancer: Clinical Features and Urinary Excretion of 17-Ketosteroids and Estrogen. Ann Surg (1945) 3.65
Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer (1980) 3.37
Purification of a human prostate specific antigen. Invest Urol (1979) 3.11
Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil Steril (1986) 3.08
New radiographic grading scales for osteoarthritis of the hand. Reliability for determining prevalence and progression. Arthritis Rheum (1989) 2.77
Carcinoembryonic antigen in patients with different cancers. JAMA (1972) 2.56
Predicting femoral neck strength from bone mineral data. A structural approach. Invest Radiol (1990) 2.55
Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin (1993) 2.43
The evaluation of morphological characteristics of human spermatozoa according to stricter criteria. Hum Reprod (1990) 2.29
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer (1998) 2.15
Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology (1990) 2.13
Transthoracic needle aspiration biopsy of benign and malignant lung lesions. AJR Am J Roentgenol (1985) 2.05
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology (1998) 2.04
American Joint Committee on Cancer prognostic factors consensus conference. Cancer (1999) 2.02
Isolation frequency and growth properties of HIV-variants: multiple simultaneous variants in a patient demonstrated by molecular cloning. J Med Virol (1987) 1.92
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res (1988) 1.91
The association of body weight, body fatness and body fat distribution with osteoarthritis of the knee: data from the Baltimore Longitudinal Study of Aging. J Rheumatol (1995) 1.86
Association of radiographic features of osteoarthritis of the knee with knee pain: data from the Baltimore Longitudinal Study of Aging. Arthritis Care Res (1995) 1.85
CT evaluation of amyloidosis: spectrum of disease. Radiographics (1993) 1.77
SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature (1971) 1.77
Race-related differences in breast cancer patients. Results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer (1985) 1.76
Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer (1981) 1.73
Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate (1999) 1.71
Secondary carcinomas of the kidney. J Urol (1975) 1.59
The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer (1999) 1.58
Clinical highlights from the National Cancer Data Base: 1994. CA Cancer J Clin (1994) 1.58
The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet (1984) 1.54
Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli. J Gen Microbiol (1992) 1.48
The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment. Cancer (1997) 1.47
Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1994) 1.46
HIV-1 and HIV-2 infections in a high-risk population in Bombay, India: evidence for the spread of HIV-2 and presence of a divergent HIV-1 subtype. J Acquir Immune Defic Syndr (1992) 1.42
Sex differences in geometry of the femoral neck with aging: a structural analysis of bone mineral data. Calcif Tissue Int (1992) 1.41
The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer (1991) 1.39
The prevalence of mixed-species and antifolate-resistant malaria infections in Mpumalanga. S Afr Med J (1998) 1.39
Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J Ultrasound Med (1984) 1.37
Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer (1988) 1.35
CEA as a monitor of gastrointestinal malignancy. Cancer (1975) 1.33
Influenza surveillance: experiences from establishing a sentinel surveillance system in Germany. J Epidemiol Community Health (1995) 1.29
Association of hand and knee osteoarthritis: evidence for a polyarticular disease subset. Ann Rheum Dis (1996) 1.29
CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J Surg Oncol (1998) 1.29
Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons. J Urol (1986) 1.29
Beta adrenergic blockade. Hemodynamics and myocardial energy metabolism in patients with ischemic heart disease. Am J Cardiol (1968) 1.28
Pulmonary hamartoma: CT findings. Radiology (1986) 1.28
Familial aggregation of osteoarthritis: data from the Baltimore Longitudinal Study on Aging. Arthritis Rheum (1998) 1.27
Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons. Ann Surg (1980) 1.27
Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer. Cancer (1993) 1.27
Isolation of variants of lymphocytopathic retroviruses from the peripheral blood and cerebrospinal fluid of patients with ARC or AIDS. J Med Virol (1986) 1.26
The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1996) 1.25
The association of benign prostatic hyperplasia and cancer of the prostate. Cancer (1992) 1.22
In vivo regulation of rRNA transcription occurs rapidly in nondividing and dividing Drosophila cells in response to a phorbol ester and serum. Mol Cell Biol (1993) 1.20
Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J Clin Invest (1979) 1.20
Prostate antigen: a new potential marker for prostatic cancer. Prostate (1981) 1.18
Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients. Prostate Suppl (1996) 1.17
Articular and diaphyseal remodeling of the proximal femur with changes in body mass in adults. Am J Phys Anthropol (1991) 1.14
The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer (1996) 1.13
Irregular fatty infiltration of the liver: diagnostic dilemmas. AJR Am J Roentgenol (1980) 1.13
Correlations of the orthogonal electrocardiogram and vectorcardiogram with consitutional variables in 518 normal men. Circulation (1967) 1.12
Amyloidosis: an overview. Semin Roentgenol (1986) 1.11
Effect of ethanol on metabolism and function of perfused rat heart. Am Heart J (1969) 1.11
Follow-up evaluation of a phase II prostate cancer vaccine trial. Prostate (1999) 1.11
Cardiomyopathy in crowded rabbits. A preliminary report. S Afr Med J (1973) 1.10
Use of human prostate-specific antigen in monitoring prostate cancer. Cancer Res (1981) 1.10
Progressive familial heart block--two types. S Afr Med J (1977) 1.09
Why is the prostate cancer death rate declining in the United States? Cancer (1998) 1.09
A murine renal cell carcinoma. J Natl Cancer Inst (1973) 1.09
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. Prostate (1998) 1.09
A prostate antigen in sera of prostatic cancer patients. Cancer Res (1980) 1.08
Matrix metalloproteinase homologues from Arabidopsis thaliana. Expression and activity. J Biol Chem (1999) 1.07
Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors. AIDS (1997) 1.07
Yersinia enterocolitica in the Western Cape. S Afr Med J (1973) 1.07
Management and survival of carcinoma of the colon: results of a national survey by the American College of Surgeons. Ann Surg (1978) 1.07
Prostate cancer: progress and change. CA Cancer J Clin (1978) 1.06
The longitudinal course of hand osteoarthritis in a male population. Arthritis Rheum (1990) 1.06
Current percolation and anisotropy in polycrystalline MgB(2). Phys Rev Lett (2003) 1.06
The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer (1979) 1.05
Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer J Clin (1993) 1.05
Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. Prostate (1997) 1.05
A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program. Cancer (1997) 1.05
Oligozoospermia: a seven-year survey of the incidence, chromosomal aberrations, treatment and pregnancy rate. Int J Fertil (1975) 1.05
Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res (1980) 1.04
Prostate-specific membrane antigen: current and future utility. Semin Urol Oncol (1998) 1.04
The National Cancer Data Base report on longitudinal observations on prostate cancer. Cancer (1996) 1.04
Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology (2000) 1.04
The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol (1982) 1.04
American Cancer Society guideline for the early detection of prostate cancer: update 1997. CA Cancer J Clin (1997) 1.04
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
Method for identifying prostate cells in semen using flow cytometry. Prostate (1998) 1.04
Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin. J Urol (1975) 1.03
Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation. Invest Urol (1978) 1.03
Chemotherapy programs of the National Prostatic Cancer Project (NPCP). Cancer (1980) 1.03